| P50 | author | David M. Holtzman | Q56827171 |
| | Terrie Inder | Q89646096 |
| | Diego Morales | Q42856284 |
| P2093 | author name string | James P McAllister | |
| | David D Limbrick | |
| | Michael J Wallendorf | |
| | Clinton D Morgan | |
| | Jennifer Strahle | |
| | Deanna Mercer | |
| | Gakwaya Habiyaremye | |
| | Brandon Baksh | |
| P2860 | cites work | Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein | Q22241520 |
| | A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. | Q24631193 |
| | Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease | Q26999922 |
| | Cellular functions of the amyloid precursor protein from development to dementia | Q28087171 |
| | Pathophysiology of congenital and neonatal hydrocephalus | Q28271225 |
| | APP processing and synaptic function | Q29615873 |
| | Hydrocephalus in children | Q30053622 |
| | Brain-wide pathway for waste clearance captured by contrast-enhanced MRI | Q30536631 |
| | Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature | Q30928368 |
| | High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. | Q33391309 |
| | Intraventricular infusion of hyperosmolar dextran induces hydrocephalus: a novel animal model of hydrocephalus | Q33517929 |
| | Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus | Q34021084 |
| | Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus | Q34115835 |
| | Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test. | Q50643287 |
| | Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome. | Q52139716 |
| | Interleukin-1beta, interleukin-18, and interferon-gamma expression in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus--markers of white matter damage? | Q52926594 |
| | Tau protein is a potential biological marker for normal pressure hydrocephalus | Q73769901 |
| | S-100 protein as marker of the blood-brain barrier disruption in children with internal hydrocephalus and epilepsy--a preliminary study | Q81243112 |
| | Cerebrospinal fluid obstruction and malabsorption in human neonatal hydrocephaly | Q83340280 |
| | Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus | Q83716415 |
| | Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes | Q84778510 |
| | [Diagnostic value of CSF biomarker profile in idiopathic normal pressure hydrocephalus; leucine-rich α-2-glycoprotein is a potential biological marker] | Q84950308 |
| | Expression of soluble Fas in the cerebrospinal fluid of preterm infants with posthemorrhagic hydrocephalus and cystic white matter damage | Q85211750 |
| | Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus | Q85582767 |
| | Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers | Q86370822 |
| | Alterations in brain metabolism, CNS morphology and CSF dynamics in adult rats with kaolin-induced hydrocephalus | Q43868571 |
| | Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus | Q45786410 |
| | Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus | Q46573885 |
| | Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus. | Q46853768 |
| | CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. | Q46961181 |
| | Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion Molecule | Q47142829 |
| | Frontal and occipital horn ratio: A linear estimate of ventricular size for multiple imaging modalities in pediatric hydrocephalus | Q47272613 |
| | Cell Junction Pathology of Neural Stem Cells Is Associated With Ventricular Zone Disruption, Hydrocephalus, and Abnormal Neurogenesis. | Q48126602 |
| | Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases | Q48149510 |
| | Serotonin and 5-hydroxy indole acetic acid in infantile hydrocephalus | Q48230962 |
| | Expression of HGF, MMP-9 and TGF-β1 in the CSF and cerebral tissue of adult rats with hydrocephalus | Q48238792 |
| | Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus | Q48244860 |
| | Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients | Q48297393 |
| | Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus | Q48308437 |
| | Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases | Q48380914 |
| | Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. | Q48391220 |
| | Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease | Q48446090 |
| | Cerebral white matter oxidation and nitrosylation in young rodents with kaolin-induced hydrocephalus | Q48603535 |
| | Dynamics of brain-derived proteins in cerebrospinal fluid | Q48747345 |
| | Effects of hydrocephalus and ventriculoperitoneal shunt therapy on afferent and efferent connections in the feline sensorimotor cortex | Q48925258 |
| | Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases | Q49020130 |
| | Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics | Q34268087 |
| | Is there a cerebral lymphatic system? | Q34346927 |
| | Impairment of paravascular clearance pathways in the aging brain | Q34577109 |
| | Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus | Q34595719 |
| | Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury | Q34614529 |
| | The pathophysiology underlying repetitive mild traumatic brain injury in a novel mouse model of chronic traumatic encephalopathy | Q34880054 |
| | Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus | Q35123209 |
| | Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers | Q35137002 |
| | Cerebrospinal fluid levels of amyloid precursor protein are associated with ventricular size in post-hemorrhagic hydrocephalus of prematurity | Q35147554 |
| | The Cerebral Surfactant System and Its Alteration in Hydrocephalic Conditions. | Q36140453 |
| | Alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus of prematurity | Q36208954 |
| | Increased CSF osmolarity reversibly induces hydrocephalus in the normal rat brain | Q36383908 |
| | Sequential morphological and functional changes in kaolin-induced hydrocephalus | Q36599307 |
| | Diffusion tensor imaging with direct cytopathological validation: characterisation of decorin treatment in experimental juvenile communicating hydrocephalus. | Q36955541 |
| | Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau | Q37269006 |
| | Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain | Q37277317 |
| | Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: glial proteins associated with cell damage and loss. | Q37426105 |
| | Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport | Q37701379 |
| | Neuropathology and structural changes in hydrocephalus | Q37737202 |
| | Biomarkers in neonatal posthemorrhagic hydrocephalus | Q37906143 |
| | The neuropathology and neurobiology of traumatic brain injury | Q38065400 |
| | A cell junction pathology of neural stem cells leads to abnormal neurogenesis and hydrocephalus. | Q38071228 |
| | Riding the wave of ependymal cilia: genetic susceptibility to hydrocephalus in primary ciliary dyskinesia | Q38107881 |
| | Structure and function of the ependymal barrier and diseases associated with ependyma disruption | Q38232080 |
| | Hydrocephalus-induced changes in the composition of cerebrospinal fluid | Q38363845 |
| | Cilia in the choroid plexus: their roles in hydrocephalus and beyond. | Q38366579 |
| | An update on research priorities in hydrocephalus: overview of the third National Institutes of Health-sponsored symposium "Opportunities for Hydrocephalus Research: Pathways to Better Outcomes". | Q38389056 |
| | Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus | Q38534131 |
| | Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice | Q38825497 |
| | Planar Organization of Multiciliated Ependymal (E1) Cells in the Brain Ventricular Epithelium | Q38867478 |
| | A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus | Q39901305 |
| | Implications of the discovery of brain lymphatic pathways | Q41991719 |
| | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Q42062882 |
| | Neonatal high pressure hydrocephalus is associated with elevation of pro-inflammatory cytokines IL-18 and IFNgamma in cerebrospinal fluid | Q42205577 |
| | "Compensated hyperosmolarity" of cerebrospinal fluid and the development of hydrocephalus | Q42257264 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| | hydrocephalus | Q193003 |
| | congenital disorder | Q727096 |
| | biomarker | Q864574 |
| P304 | page(s) | e0172353 | |
| P577 | publication date | 2017-02-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus | |
| P478 | volume | 12 | |